Yardley, PA, United States of America

Raymond Joseph Patch

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 8.9

ph-index = 5

Forward Citations = 136(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Innovations by Raymond Joseph Patch in Biotechnology

Introduction

Raymond Joseph Patch is a prominent innovator based in Yardley, PA. With an impressive portfolio of 20 patents, he has made significant contributions to the field of biotechnology, particularly in the development of compounds that interact with neuropeptide Y receptors.

Latest Patents

Among his latest innovations, Patch has developed antibody-coupled cyclic peptide tyrosine tyrosine compounds. This novel invention comprises conjugates that include a monoclonal antibody linked to a cyclic PYY peptide. These conjugates are designed to prevent, treat, or ameliorate various diseases and disorders, as detailed in his patent application. Additionally, he has patented cyclic peptide tyrosine tyrosine compounds, which consist of specific compounds of Formula I that also act as modulators of neuropeptide Y receptors.

Career Highlights

During his career, Patch has held positions at notable companies such as Janssen Pharmaceutica NV and 3-Dimensional Pharmaceuticals, Inc. His work has not only emphasized the importance of biotechnology in healthcare but also the therapeutic potential these innovations represent.

Collaborations

Throughout his journey as an inventor, Patch has collaborated with esteemed professionals in the field, including Mark James Wall and Mark J. Macielag. These partnerships have contributed to advancing his research and innovations.

Conclusion

Raymond Joseph Patch continues to be a driving force in the biotechnology sector with his innovative patents and collaborative efforts. His work focusing on neuropeptide modulation provides a foundation for future therapeutic advancements in combating various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…